Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease - PubMed (original) (raw)
. 2008 Nov 15;168(10):1179-89.
doi: 10.1093/aje/kwn229. Epub 2008 Oct 3.
Affiliations
- PMID: 18835864
- PMCID: PMC2582058
- DOI: 10.1093/aje/kwn229
Association of adiposity status and changes in early to mid-adulthood with incidence of Alzheimer's disease
May A Beydoun et al. Am J Epidemiol. 2008.
Abstract
Adiposity status and change are potential risk factors for Alzheimer's disease (AD). The authors used data on 2,322 participants in the Baltimore Longitudinal Study of Aging to analyze the relation between AD incidence and adiposity in Cox proportional hazards models, with adjustment for sociodemographic factors and smoking status. Body mass index (BMI; weight (kg)/height (m)(2)) and waist circumference at specific ages were predicted by empirical Bayes estimators from mixed-effects regression models. After a median of 23.4 years of follow-up between 1958 and 2006, 187 participants developed AD. Among men, being underweight (BMI <or=18.5) at age 30, 40, or 45 years increased the likelihood of AD (hazard ratio (HR) = 5.76, 95% confidence interval (CI): 2.07, 16.00); among women, being obese (BMI >or=30) at age 30, 40, or 45 years and jointly centrally obese (waist circumference >or=80th percentile) at age 30, 35, or 50 years increased AD risk (HR = 6.57, 95% CI: 1.96, 22.02). Women who lost weight (BMI change <10th percentile) between ages 30 and 45 years were also at increased risk (HR = 2.02, 95% CI: 1.06, 3.85). Weight gain among men (BMI change >90th percentile) between ages 30 and 50 years increased AD risk (HR = 3.70, 95% CI: 1.43, 9.56). Future studies should identify age- and gender-specific optimal weights and weight-loss strategies for preventing AD and investigate potential mechanisms.
Figures
Figure 1.
Procedures used for inclusion and exclusion of Baltimore Longitudinal Study of Aging (BLSA) participants in analyses of the relation between adiposity and Alzheimer's disease (AD) risk, 1958–2006. Sample 1 was used for prediction of body mass index/waist circumference with linear mixed models; samples 2a and 2b were used for fitting Cox proportional hazards models and constructing Kaplan-Meier survival curves. Solid line: subjects included in analysis; dashed line: subjects not included in analysis.
Figure 2.
Kaplan-Meier survival curve for time to incident Alzheimer's disease by adiposity risk status (elevated body mass index and waist circumference (obese at age 30, 40, or 45 years and in upper quintile of waist circumference at age 30, 35, or 50 years) vs. no elevation) among women, Baltimore Longitudinal Study of Aging, 1958–2006. The hazard ratio was 6.57 (95% confidence interval: 1.96, 22.02; P < 0.01; log-rank test: P = 0.0003). Failure was defined as first diagnosis of incident Alzheimer's disease at or after age 50 years. Hazard ratios were adjusted for education, race/ethnicity, smoking status, and year of birth.
Figure 3.
Kaplan-Meier survival curve for time to incident Alzheimer's disease by adiposity risk status (significant decrease in body mass index (change <10th percentile) during any 5-year interval between ages 35 and 45 years vs. none) among women, Baltimore Longitudinal Study of Aging, 1958–2006. The hazard ratio was 2.02 (95% confidence interval: 1.06, 3.85; P < 0.05; log-rank test: P = 0.0266). Failure was defined as first diagnosis of incident Alzheimer's disease at or after age 50 years. Hazard ratios were adjusted for education, race/ethnicity, smoking status, and year of birth.
Figure 4.
Kaplan-Meier survival curve for time to incident Alzheimer's disease by adiposity risk status (underweight (at age 30, 40, or 45 years vs. not underweight) among men, Baltimore Longitudinal Study of Aging, 1958–2006. The hazard ratio was 5.76 (95% confidence interval: 2.07, 16.00; P < 0.001; log-rank test: P = 0.001). Failure was defined as first diagnosis of incident Alzheimer's disease at or after age 50 years. Hazard ratios were adjusted for education, race/ethnicity, smoking status, and year of birth.
Figure 5.
Kaplan-Meier survival curve for time to incident Alzheimer's disease by adiposity risk status (increase in body mass index (change >90th percentile) during any 5-year interval between ages 30 and 50 years vs. no increase) among men, Baltimore Longitudinal Study of Aging, 1958–2006. The hazard ratio was 3.70 (95% confidence interval: 1.43, 9.56; P < 0.01; log-rank test P = 0.0166). Failure was defined as first diagnosis of incident Alzheimer's disease at or after age 50 years. Hazard ratios were adjusted for education, race/ethnicity, smoking status, and year of birth.
Similar articles
- Body mass index in midlife and risk of Alzheimer disease and vascular dementia.
Whitmer RA, Gunderson EP, Quesenberry CP Jr, Zhou J, Yaffe K. Whitmer RA, et al. Curr Alzheimer Res. 2007 Apr;4(2):103-9. doi: 10.2174/156720507780362047. Curr Alzheimer Res. 2007. PMID: 17430231 - Measures of Adiposity and Alzheimer's Disease-Related MRI Markers: The Northern Manhattan Study.
Caunca MR, Simonetto M, Alperin N, Elkind MSV, Sacco RL, Wright CB, Rundek T. Caunca MR, et al. J Alzheimers Dis. 2019;70(4):995-1004. doi: 10.3233/JAD-190092. J Alzheimers Dis. 2019. PMID: 31306120 Free PMC article. - Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study.
Portugal B, Artaud F, Domenighetti C, Roze E, Degaey I, Canonico M, Elbaz A. Portugal B, et al. Neurology. 2023 Jan 17;100(3):e324-e335. doi: 10.1212/WNL.0000000000201468. Epub 2022 Oct 3. Neurology. 2023. PMID: 36192171 - [Body mass index and cancer incidence:a prospective cohort study in northern China].
Guo L, Li N, Wang G, Su K, Li F, Yang L, Ren J, Chang S, Chen S, Wu S, He J, Dai M. Guo L, et al. Zhonghua Liu Xing Bing Xue Za Zhi. 2014 Mar;35(3):231-6. Zhonghua Liu Xing Bing Xue Za Zhi. 2014. PMID: 24831616 Chinese. - Life Course Adiposity and Alzheimer's Disease: A Mendelian Randomization Study.
Li X, Tian Y, Yang YX, Ma YH, Shen XN, Chen SD, Dong Q, Tan L, Yu JT. Li X, et al. J Alzheimers Dis. 2021;82(2):503-512. doi: 10.3233/JAD-210345. J Alzheimers Dis. 2021. PMID: 34057091
Cited by
- Relationship between dietary phytoestrogens and development of urinary incontinence in midlife women.
Waetjen LE, Leung K, Crawford SL, Huang MH, Gold EB, Greendale GA; Study of Women’s Health Across the Nation. Waetjen LE, et al. Menopause. 2013 Apr;20(4):428-36. doi: 10.1097/gme.0b013e3182703c9c. Menopause. 2013. PMID: 23096248 Free PMC article. - The protective effect of early dietary fat consumption on Alzheimer's disease-related pathology and cognitive function in mice.
Amelianchik A, Merkel J, Palanisamy P, Kaneki S, Hyatt E, Norris EH. Amelianchik A, et al. Alzheimers Dement (N Y). 2021 May 25;7(1):e12173. doi: 10.1002/trc2.12173. eCollection 2021. Alzheimers Dement (N Y). 2021. PMID: 34084889 Free PMC article. - Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers.
Zhong G, Wang Y, Zhang Y, Guo JJ, Zhao Y. Zhong G, et al. PLoS One. 2015 Mar 12;10(3):e0118333. doi: 10.1371/journal.pone.0118333. eCollection 2015. PLoS One. 2015. PMID: 25763939 Free PMC article. Review. - Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?
Akter K, Lanza EA, Martin SA, Myronyuk N, Rua M, Raffa RB. Akter K, et al. Br J Clin Pharmacol. 2011 Mar;71(3):365-76. doi: 10.1111/j.1365-2125.2010.03830.x. Br J Clin Pharmacol. 2011. PMID: 21284695 Free PMC article. Review. - Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
Chuang YF, An Y, Bilgel M, Wong DF, Troncoso JC, O'Brien RJ, Breitner JC, Ferruci L, Resnick SM, Thambisetty M. Chuang YF, et al. Mol Psychiatry. 2016 Jul;21(7):910-5. doi: 10.1038/mp.2015.129. Epub 2015 Sep 1. Mol Psychiatry. 2016. PMID: 26324099 Free PMC article.
References
- Hendrie HC. Epidemiology of dementia and Alzheimer's disease. Am J Geriatr Psychiatry. 1998;6(2 suppl 1):S3–S18. - PubMed
- Gorospe EC, Dave JK. The risk of dementia with increased body mass index. Age Ageing. 2007;36(1):23–29. - PubMed
- Rosengren A, Skoog I, Gustafson D, et al. Body mass index, other cardiovascular risk factors, and hospitalization for dementia. Arch Intern Med. 2005;165(3):321–326. - PubMed
- Whitmer RA, Gunderson EP, Quesenberry CP, Jr, et al. Body mass index in midlife and risk of Alzheimer disease and vascular dementia. Curr Alzheimer Res. 2007;4(2):103–109. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical